How to cure mycoplasma pneumonia
The treatment of pediatric mycoplasma pneumonia is basically the same as that of general pneumonia, and comprehensive treatment measures are adopted. It includes five aspects: general treatment, symptomatic treatment, antibiotic use, adrenocorticosteroids, and treatment of extrapulmonary complications. For anti-infective therapy, in view of the biological characteristics of mycoplasma intracellular parasitism, the course of treatment is generally not less than 2~3 weeks, usually 3~6 weeks, and there are also longer courses of treatment, and it is easy to relapse if the drug is stopped too early. Oral therapy can be divided into doses for mild cases, intravenous administration can be considered for severe cases, and the general principle of clinicians is to consolidate treatment with oral antibiotics for 2 weeks after clinical cure.
The follow-up examination found that the body temperature was normal and there was no difficulty in breathing; During auscultation, there are not many crackles in the lungs, and there is no wheezing, which can be considered to be basically cured.
However, there may be some residual mycoplasma pathogens in the respiratory system, which can irritate the respiratory tract and cause coughing.
IgM antibody titers are an important indicator for confirming mycoplasma pneumonia, but are not used to determine whether the disease is cured. Antibodies are like an army produced by the body's immune system against a certain type of pathogen, if the pathogen invades the body, the body will produce corresponding antibodies to fight the pathogen, just like gathering soldiers to defend the city; When the pathogen is eliminated, the soldiers will gradually disband, and the number will slowly decrease. The titer of IgM antibody has a certain correlation with the severity of the disease, but it is not completely synchronized, and it is not based on this indicator to evaluate whether mycoplasma pneumonia is cured clinically. In most cases, IgM antibody titers do not become normal until two weeks after the pathogen has been completely cleared. Therefore, there is no need to be too entangled when this indicator is too high, but it can be used as a basis for observation and evaluation of mycoplasma to stop replication.
Most adults have mycoplasma in their respiratory tract, which can easily invade a child's respiratory tract through daily contact and may recur if resistance is low. The recurrence of the disease has a lot to do with the presence of pathogens in the environment, as well as its own sensitivity to pathogens and its own resistance.
Once mycoplasma enters the cells of lung tissue, it is difficult to get rid of it. Treatment with antibiotics, such as erythromycin or azithromycin, only removes mycoplasma from the blood; However, it has little effect on mycoplasma that exists in tissue cells, so when the resistance is low, the mycoplasma may multiply into the bloodstream and cause the disease to recur.But on the other hand, once mycoplasma multiplies in the body and induces the body to produce IgM antibodies, it will have a certain immune effect on mycoplasma, which is equivalent to the existence of an army against this pathogen in the body, and the resistance to the disease will be stronger.
If the child has just been cured of mycoplasma pneumonia but has recently developed cough and fever, it is recommended that parents give their children azithromycin at home for 3 days, and then visit the doctor for evaluation after the effect is not obvious. Because in addition to targeting mycoplasma, azithromycin also has an inhibitory effect on other pathogens.